Saturna Capital’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Saturna Capital’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-333	Closed	-$35K	–	414
2014 Q2	$35K	Hold	333	–	–	﹤0.01%	338
2014 Q1	$29K	Sell	333 -100	-23%	-$7.72K	﹤0.01%	306
2013 Q4	$18K	Hold	433	–	–	﹤0.01%	322
2013 Q3	$19K	Hold	433	–	–	﹤0.01%	333
2013 Q2	$15K	Buy	+433	New	+$15.2K	﹤0.01%	345

Saturna Capital's FURX Position: Q3 2014 in Review

Saturna Capital sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 333 shares — an estimated $35K sold.

Saturna Capital first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $35K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

Saturna Capital reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
Saturna Capital sold 333 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $35K.
Saturna Capital first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
Saturna Capital's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $35K in Q2 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Saturna Capital's 13F filing for Q3 2014, filed 13 Nov 2014.